Appropriateness of treatment recommendations for PPI in hospital discharge letters

被引:92
作者
Ahrens, Dirk [1 ]
Chenot, Jean-Francois [1 ]
Behrens, Gesa [1 ]
Grimmsmann, Thomas [2 ]
Kochen, Michael M. [1 ]
机构
[1] Univ Gottingen, Dept Gen Practice, D-37073 Gottingen, Germany
[2] Statutory Hlth Insurance Funds Mecklenburg Vorpom, Med Review Board, Schwerin, Germany
关键词
Proton pump inhibitors; Germany; PROTON PUMP INHIBITORS; HELICOBACTER-PYLORI INFECTION; ACID-SUPPRESSIVE THERAPY; RISK; PREVENTION; GUIDELINES; MANAGEMENT; ARTICLE; COMPLICATIONS; MEDICATIONS;
D O I
10.1007/s00228-010-0871-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The reasons for the dramatic increase in proton pump inhibitors (PPI) prescriptions remain unclear and cannot be explained solely by increased morbidity, new indications or a decrease in alternative medication. Inappropriate use and discharge recommendations in hospitals are considered to be possible explanations. As the quality of PPI recommendations in hospital discharge letters in Germany has not been investigated to date, we have studied the appropriateness of these referrals. Hospital discharge letters with recommendations for PPI medication from 35 primary care practices in the county of Mecklenburg-Western Pomerania (MV; North-east Germany) were collected and analysed, and the appropriateness of the PPI indication was rated. No information justifying the recommendation for continuous PPI medication could be identified in 54.5% of the discharge letters; in 12.7%, the indication was uncertain, and in 32.7%, we found an evidence-based indication for PPI medication. The most common indication for adequate PPI use was nonsteroidal anti-inflammatory drug-prophylaxis in high-risk patients. Inadequate recommendations for PPIs in discharge letters are frequent. This may lead to a continuation of this therapy in primary care, thereby unnecessarily increasing polypharmacy and the risk of adverse events as well as burdening the public health budget. Hospitals should therefore critically review recommendations for PPI medication and the dosage thereof in their discharge letters and clearly document the reason for PPI use and the need for continuous prescription in primary care.
引用
收藏
页码:1265 / 1271
页数:7
相关论文
共 38 条
  • [1] [Anonymous], 1999, Am J Health Syst Pharm, V56, P347, DOI [10.1093/ajhp/56.4.347, DOI 10.1093/AJHP/56.4.347]
  • [2] Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - Update 2004
    Armstrong, D
    Marshall, JK
    Chiba, N
    Enns, R
    Fallone, CA
    Fass, R
    Hollingworth, R
    Hunt, RH
    Kahrilas, PJ
    Mayrand, S
    Moayyedi, P
    Paterson, WG
    Sadowski, D
    van Zanten, SJV
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (01): : 15 - 35
  • [3] Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment
    Chan, FKL
    Graham, DY
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (10) : 1051 - 1061
  • [4] RISK-FACTORS FOR GASTROINTESTINAL-BLEEDING IN CRITICALLY ILL PATIENTS
    COOK, DJ
    FULLER, HD
    GUYATT, GH
    MARSHALL, JC
    LEASA, D
    HALL, R
    WINTON, TL
    RUTLEDGE, F
    TODD, TJR
    ROY, P
    LACROIX, J
    GRIFFITH, L
    WILLAN, A
    NOSEWORTHY, T
    POWLES, P
    OPPENHEIMER, L
    HEWSON, J
    LANG, J
    LEE, H
    GUSLITS, B
    HEULE, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (06) : 377 - 381
  • [5] Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
    Dial, S
    Delaney, JAC
    Barkun, AN
    Suissa, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23): : 2989 - 2995
  • [6] Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy
    Dubois, RW
    Melmed, GY
    Henning, JM
    Laine, L
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (02) : 197 - 208
  • [7] Review article: role of proton pump inhibitors in non-H. pylori-related ulcers
    Freston, JW
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 : 2 - 5
  • [8] The influence of hospitalisation on drug prescription in primary care - a large-scale follow-up study
    Grimmsmann, Thomas
    Schwabe, Ulrike
    Himmel, Wolfgang
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (08) : 783 - 790
  • [9] The choice of proton pump inhibitor:: Does it matter?
    Hellström, PM
    Vitols, S
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 94 (03) : 106 - 111
  • [10] Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
    Ho, P. Michael
    Maddox, Thomas M.
    Wang, Li
    Fihn, Stephan D.
    Jesse, Robert L.
    Peterson, Eric D.
    Rumsfeld, John S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (09): : 937 - 944